NDAINTRAVENOUSINJECTABLE
Approved
Aug 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
FLUDEOXYGLUCOSE F18 (fludeoxyglucose f18) by Medica Corp is radiopharmaceutical activity [moa]. First approved in 2005.
Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLUDEOXYGLUCOSE F18 is a radiopharmaceutical diagnostic agent administered intravenously that uses positron emission tomography (PET) imaging to detect metabolic activity in tissues. It is a glucose analog labeled with fluorine-18 that accumulates in areas of high glucose metabolism, primarily used for oncology, neurology, and cardiology imaging. This is a diagnostic tool rather than a therapeutic agent.
LOE Approaching
LOE approaching signals potential downsizing of brand commercial teams; career growth opportunities are limited unless organization invests in next-generation PET imaging agents.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
FLUDEOXYGLUCOSE F18 offers limited career growth due to its mature, commoditized market position and approaching loss of exclusivity. Roles available are primarily focused on supply chain optimization, regulatory maintenance, and cost management rather than innovation or commercial expansion.
Supply Chain ManagerRegulatory Affairs Specialist
Worked on FLUDEOXYGLUCOSE F18 at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.